Current research in other cancer types has revealed that the identity of some DCs shifts from promoting “immune killing” to facilitating “immune suppression.” DCs can secrete TGF-β to activate the Smad signaling pathway, thereby promoting the expression of the transcription factor FoxP3 and driving the functional differentiation of Tregs (90). This evidence concerns the gene TGFB1 and cancer.